Evidence map›Paper›PMID 38882276›Full record

ArticleHeliyon2024

Assessment of

Om Kolthoom M Weisy, Reena A Kedia, Ibrahim Mahmoud, Raed O Abu Odeh, Bashair M Mussa, Salah Abusnana, Sameh S M Soliman, Jibran Sualeh Muhammad, Mohamad Hamad, Rose Ghemrawi and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Om Kolthoom M WeisyDepartment of Pharmaceutics and Pharmaceuticals Technology, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Reena A KediaResearch Institute for Medical & Health Sciences, University of Sharjah, United Arab Emirates.
Ibrahim MahmoudDepartment of Family and Community Medicine and Behavioral Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Raed O Abu OdehResearch Institute for Medical & Health Sciences, University of Sharjah, United Arab Emirates.
Bashair M MussaDepartment of Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates.
Salah AbusnanaDiabetes and Endocrinology Department, University Hospital Sharjah, Sharjah, United Arab Emirates.
Sameh S M SolimanDepartment of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.
Jibran Sualeh MuhammadResearch Institute for Medical & Health Sciences, University of Sharjah, United Arab Emirates.
Mohamad HamadResearch Institute for Medical & Health Sciences, University of Sharjah, United Arab Emirates.
Rose GhemrawiCollege of Pharmacy, Al Ain University, Abu Dhabi, United Arab Emirates.
Ghalia KhoderDepartment of Pharmaceutics and Pharmaceuticals Technology, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The United Arab Emirates (UAE) serves as an effective epidemiological site for assessing

Indexed as

CagAELISAFerritinGastric cancerH. pyloriSharjahUAEVitamin B12

Identifiers

PMID38882276
PMCPMC11180313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.